UncategorizedHCW Biologics advances TRBC-pembrolizumab immune checkpoint inhibitor for solid tumor trials – Longevity.Technology Empower Meds / September 17, 2025
UncategorizedAnnovis reports similar pharmacokinetics for new crystal buntanetap – Longevity.Technology Empower Meds / September 17, 2025
UncategorizedINBRAIN Neuroelectronics collaborates with Mayo Clinic to advance graphene BCIs – Longevity.Technology Empower Meds / September 17, 2025
UncategorizedMesoblast highlights Ryoncil launch success at US healthcare conferences – Longevity.Technology Empower Meds / September 16, 2025
UncategorizedAlterity reveals positive Phase 2 results for ATH434 in Multiple System Atrophy – Longevity.Technology Empower Meds / September 16, 2025
UncategorizedBioAge begins Phase 1 study of BGE-102 NLRP3 inhibitor – Longevity.Technology Empower Meds / September 16, 2025
UncategorizedGenflow secures CDAs to explore animal health use of its longevity gene therapy – Longevity.Technology Empower Meds / September 16, 2025
